DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Crosby T, Hurt CN, Falk S et al.
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentric, phase 2/3 randomised trial.
Lancet Oncol 2013;
14: 627-637
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.